Loading...

Quantum Health Group

DB:QD4
Snowflake Description

Undervalued with adequate balance sheet.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
QD4
DB
A$27M
Market Cap
  1. Home
  2. DE
  3. Healthcare
Company description

Quantum Health Group Limited distributes medical imaging and patient treatment equipment and services in Australia, Thailand, South Korea, Vietnam, New Zealand, and China. The last earnings update was 107 days ago. More info.


Add to Portfolio Compare Print
  • Quantum Health Group has significant price volatility in the past 3 months.
QD4 Share Price and Events
7 Day Returns
-7.8%
DB:QD4
0.7%
DE Healthcare
-3.6%
DE Market
1 Year Returns
18.6%
DB:QD4
-29.1%
DE Healthcare
-11.8%
DE Market
QD4 Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Quantum Health Group (QD4) -7.8% -30.8% -40.7% 18.6% -48.1% 107.5%
DE Healthcare 0.7% -5.6% -4.6% -29.1% -17.6% 31.7%
DE Market -3.6% -2.1% -0.8% -11.8% 12% 5.8%
1 Year Return vs Industry and Market
  • QD4 outperformed the Healthcare industry which returned -29.1% over the past year.
  • QD4 outperformed the Market in Germany which returned -11.8% over the past year.
Price Volatility
QD4
Industry
5yr Volatility vs Market

Value

 Is Quantum Health Group undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of Quantum Health Group to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for Quantum Health Group.

DB:QD4 Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Extrapolated from most recent financials. See below
Discount Rate (Cost of Equity) See below 5.7%
Perpetual Growth Rate 10-Year DE Government Bond Rate 0.2%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for DB:QD4
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year DE Govt Bond Rate 0.2%
Equity Risk Premium S&P Global 6%
Healthcare Unlevered Beta Simply Wall St/ S&P Global 0.64
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.638 (1 + (1- 30%) (51.87%))
0.913
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
0.91
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 0.23% + (0.913 * 5.96%)
5.67%

Discounted Cash Flow Calculation for DB:QD4 using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for Quantum Health Group is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.

DB:QD4 DCF 1st Stage: Next 10 year cash flow forecast
Levered FCF (AUD, Millions) Source Present Value
Discounted (@ 5.67%)
2019 18.13 Est @ 96.87% 17.15
2020 30.43 Est @ 67.88% 27.26
2021 44.91 Est @ 47.58% 38.07
2022 59.90 Est @ 33.38% 48.05
2023 73.94 Est @ 23.43% 56.13
2024 86.12 Est @ 16.47% 61.87
2025 96.11 Est @ 11.6% 65.34
2026 103.98 Est @ 8.19% 66.90
2027 110.01 Est @ 5.8% 66.99
2028 114.55 Est @ 4.13% 66.01
Present value of next 10 years cash flows A$513.77
DB:QD4 DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2028 × (1 + g) ÷ (Discount Rate – g)
= A$114.55 × (1 + 0.23%) ÷ (5.67% – 0.23%)
A$2,111.02
Present Value of Terminal Value = Terminal Value ÷ (1 + r)10
= A$2,111.02 ÷ (1 + 5.67%)10
A$1,216.51
DB:QD4 Total Equity Value
Calculation Result
Total Equity Value = Present value of next 10 years cash flows + Terminal Value
= A$513.77 + A$1,216.51
A$1,730.28
Equity Value per Share
(AUD)
= Total value / Shares Outstanding
= A$1,730.28 / 1,098.31
A$1.58
DB:QD4 Discount to Share Price
Calculation Result
Non-primary Listing Adjustment Factor 1 share in DB:QD4 represents 0.332x of ASX:QTM
(This could be a different class, a depositary receipt, a different currency, or all of these things.)
0.332x
Value per Share
(Listing Adjusted, EUR)
= Value per Share (AUD) x Listing Adjustment Factor
= A$ 1.58 x 0.332
€0.52
Value per share (EUR) From above. €0.52
Current discount Discount to share price of €0.01
= -1 x (€0.01 - €0.52) / €0.52
98.4%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

Current Discount
Amount off the current price Quantum Health Group is available for.
Intrinsic value
>50%
Share price is €0.0083 vs Future cash flow value of €0.52303
Current Discount Checks
For Quantum Health Group to be considered undervalued it must be available for at least 20% below the current price. Less than 40% is even better.
  • Quantum Health Group's share price is below the future cash flow value, and at a moderate discount (> 20%).
  • Quantum Health Group's share price is below the future cash flow value, and at a substantial discount (> 40%).
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Quantum Health Group's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Quantum Health Group's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
DB:QD4 PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2018-12-31) in AUD A$0.00
ASX:QTM Share Price ** ASX (2019-06-14) in AUD A$0.03
Germany Healthcare Industry PE Ratio Median Figure of 10 Publicly-Listed Healthcare Companies 28.95x
Germany Market PE Ratio Median Figure of 424 Publicly-Listed Companies 19.7x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Quantum Health Group.

DB:QD4 PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= ASX:QTM Share Price ÷ EPS (both in AUD)

= 0.03 ÷ 0.00

8.29x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Quantum Health Group is good value based on earnings compared to the DE Healthcare industry average.
  • Quantum Health Group is good value based on earnings compared to the Germany market.
Price based on expected Growth
Does Quantum Health Group's expected growth come at a high price?
Raw Data
DB:QD4 PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 8.29x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
Not available
Germany Healthcare Industry PEG Ratio Median Figure of 7 Publicly-Listed Healthcare Companies 1.43x
Germany Market PEG Ratio Median Figure of 270 Publicly-Listed Companies 1.47x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Quantum Health Group, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Quantum Health Group's assets?
Raw Data
DB:QD4 PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2018-12-31) in AUD A$0.03
ASX:QTM Share Price * ASX (2019-06-14) in AUD A$0.03
Germany Healthcare Industry PB Ratio Median Figure of 12 Publicly-Listed Healthcare Companies 1.56x
Germany Market PB Ratio Median Figure of 576 Publicly-Listed Companies 1.76x
DB:QD4 PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= ASX:QTM Share Price ÷ Book Value per Share (both in AUD)

= 0.03 ÷ 0.03

0.96x

* Primary Listing of Quantum Health Group.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Quantum Health Group is good value based on assets compared to the DE Healthcare industry average.
X
Value checks
We assess Quantum Health Group's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Healthcare industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Healthcare industry average (and greater than 0)? (1 check)
  5. Quantum Health Group has a total score of 5/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is Quantum Health Group expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Quantum Health Group has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.

Show me the analysis anyway

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
8.6%
Expected Healthcare industry annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Quantum Health Group expected to grow at an attractive rate?
  • Unable to compare Quantum Health Group's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
  • Unable to compare Quantum Health Group's earnings growth to the Germany market average as no estimate data is available.
  • Unable to compare Quantum Health Group's revenue growth to the Germany market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
DB:QD4 Future Growth Rates Data Sources
Data Point Source Value (per year)
Germany Healthcare Industry Earnings Growth Rate Market Cap Weighted Average 8.6%
Germany Healthcare Industry Revenue Growth Rate Market Cap Weighted Average 5.8%
Germany Market Earnings Growth Rate Market Cap Weighted Average 12.7%
Germany Market Revenue Growth Rate Market Cap Weighted Average 5%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
DB:QD4 Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (5 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in AUD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
DB:QD4 Past Financials Data
Date (Data in AUD Millions) Revenue Cash Flow Net Income *
2018-12-31 70 10 3
2018-09-30 68 10 3
2018-06-30 67 10 3
2018-03-31 63 5 1
2017-12-31 59 -1 -1
2017-09-30 59 0 -1
2017-06-30 59 0 -2
2017-03-31 57 -1 -2
2016-12-31 56 -2 -2
2016-09-30 57 -3 -1
2016-06-30 59 -4 -1
2016-03-31 57 -5 0

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Unable to determine if Quantum Health Group is high growth as no earnings estimate data is available.
  • Unable to determine if Quantum Health Group is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
DB:QD4 Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (5 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from Quantum Health Group Company Filings, last reported 5 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

DB:QD4 Past Financials Data
Date (Data in AUD Millions) EPS *
2018-12-31 0.00
2018-09-30 0.00
2018-06-30 0.00
2018-03-31 0.00
2017-12-31 0.00
2017-09-30 0.00
2017-06-30 0.00
2017-03-31 0.00
2016-12-31 0.00
2016-09-30 0.00
2016-06-30 0.00
2016-03-31 0.00

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Quantum Health Group will efficiently use shareholders’ funds in the future without estimates of Return on Equity.

Next steps:

  1. Examine whether Quantum Health Group is trading at Quantum Health Group'san attractive price based on how much it is expected to earn in the future, and relative to its industry peers and the wider market.
  2. Quantum Health Group's future outlook can be gauged by looking at industry trends and market size, and determining how well-positioned the company is compared to its competitors. Take a look at other high-growth Healthcare companies here
  3. Quantum Health Group's competitive advantages and company strategy can generally be found in its financial reports archived here.
  4. Use fundamentals to screen for another stock to analyse from our database of over 75,000 companies worldwide
X
Future performance checks
We assess Quantum Health Group's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Germany market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Germany market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Quantum Health Group has a total score of 0/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has Quantum Health Group performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Quantum Health Group's growth in the last year to its industry (Healthcare).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Quantum Health Group has delivered over 20% year on year earnings growth in the past 5 years.
  • Quantum Health Group has become profitable in the last year making the earnings growth rate difficult to compare to the 5-year average.
  • Quantum Health Group has become profitable in the last year making it difficult to compare the DE Healthcare industry average.
Earnings and Revenue History
Quantum Health Group's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Quantum Health Group Company Filings, last reported 5 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

DB:QD4 Past Revenue, Cash Flow and Net Income Data
Date (Data in AUD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2018-12-31 69.83 3.40 16.70 0.17
2018-09-30 68.41 3.26 17.04 0.20
2018-06-30 66.99 3.13 17.38 0.22
2018-03-31 63.18 0.93 16.91 0.28
2017-12-31 59.37 -1.27 16.44 0.35
2017-09-30 59.02 -1.49 16.95 0.43
2017-06-30 58.68 -1.71 17.47 0.52
2017-03-31 57.35 -1.65 17.87 0.51
2016-12-31 56.02 -1.60 18.28 0.51
2016-09-30 57.41 -1.12 18.37 0.52
2016-06-30 58.80 -0.64 18.47 0.52
2016-03-31 57.31 0.37 17.56 0.48
2015-12-31 55.83 1.39 16.65 0.44
2015-09-30 47.49 1.11 15.85 0.42
2015-06-30 39.15 0.83 15.05 0.40
2015-03-31 34.51 -2.21 13.82 0.37
2014-12-31 29.86 -5.24 12.58 0.35
2014-09-30 31.00 -4.98 11.99 0.30
2014-06-30 32.14 -4.71 11.39 0.25
2014-03-31 34.41 -2.37 11.96 0.30
2013-12-31 36.68 -0.03 12.53 0.36
2013-09-30 39.33 -0.18 13.46 0.46
2013-06-30 41.99 -0.33 14.38 0.56
2013-03-31 42.86 -0.66 15.23 0.51
2012-12-31 43.73 -0.99 16.09 0.47
2012-09-30 42.68 -1.47 16.26 0.32
2012-06-30 41.63 -1.95 16.43 0.17

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • Quantum Health Group has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
  • Quantum Health Group used its assets more efficiently than the DE Healthcare industry average last year based on Return on Assets.
  • Quantum Health Group has significantly improved its use of capital last year versus 3 years ago (Return on Capital Employed).
X
Past performance checks
We assess Quantum Health Group's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Healthcare industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Quantum Health Group has a total score of 3/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is Quantum Health Group's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Quantum Health Group's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Quantum Health Group is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Quantum Health Group's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Quantum Health Group's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • Debt is covered by short term assets, assets are 2.3x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Quantum Health Group Company Filings, last reported 5 months ago.

DB:QD4 Past Debt and Equity Data
Date (Data in AUD Millions) Total Equity Total Debt Cash & Short Term Investments
2018-12-31 32.77 14.24 6.85
2018-09-30 32.77 14.24 6.85
2018-06-30 30.54 14.81 5.78
2018-03-31 30.54 14.81 5.78
2017-12-31 26.60 17.47 4.00
2017-09-30 26.60 17.47 4.00
2017-06-30 25.51 17.06 3.03
2017-03-31 25.51 17.06 3.03
2016-12-31 26.92 17.06 4.47
2016-09-30 26.92 17.06 4.47
2016-06-30 26.25 17.75 5.94
2016-03-31 26.25 17.75 5.94
2015-12-31 27.87 18.48 3.58
2015-09-30 27.87 18.48 3.58
2015-06-30 27.02 11.93 4.85
2015-03-31 27.02 11.93 4.85
2014-12-31 26.98 10.54 6.88
2014-09-30 26.98 10.54 6.88
2014-06-30 24.78 6.93 5.46
2014-03-31 24.78 6.93 5.46
2013-12-31 30.71 5.08 7.30
2013-09-30 30.71 5.08 7.30
2013-06-30 29.62 6.87 5.49
2013-03-31 29.62 6.87 5.49
2012-12-31 29.52 5.86 5.63
2012-09-30 29.52 5.86 5.63
2012-06-30 29.35 5.87 6.47
  • Quantum Health Group's level of debt (43.5%) compared to net worth is high (greater than 40%).
  • The level of debt compared to net worth has increased over the past 5 years (16.7% vs 43.5% today).
  • Debt is well covered by operating cash flow (68.7%, greater than 20% of total debt).
  • Interest payments on debt are well covered by earnings (EBIT is 6.7x coverage).
X
Financial health checks
We assess Quantum Health Group's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Quantum Health Group has a total score of 4/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is Quantum Health Group's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Quantum Health Group dividends.
If you bought €2,000 of Quantum Health Group shares you are expected to receive €0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Quantum Health Group's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Quantum Health Group's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
DB:QD4 Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
Germany Healthcare Industry Average Dividend Yield Market Cap Weighted Average of 9 Stocks 1.7%
Germany Market Average Dividend Yield Market Cap Weighted Average of 327 Stocks 3.2%
Germany Minimum Threshold Dividend Yield 10th Percentile 0.8%
Germany Bottom 25% Dividend Yield 25th Percentile 1.4%
Germany Top 25% Dividend Yield 75th Percentile 3.9%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Quantum Health Group has not reported any payouts.
  • Unable to verify if Quantum Health Group's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Quantum Health Group's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Quantum Health Group has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess Quantum Health Group's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.8%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Quantum Health Group afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Quantum Health Group has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of Quantum Health Group's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
John Walstab
COMPENSATION A$396,716
AGE 55
TENURE AS CEO 2.3 years
CEO Bio

Mr. John Andrew Walstab has been Managing Director of Quantum Energy Limited since February 7, 2017 and served as its Company Secretary. Mr. Walstab serves as the Managing Director of Insight Oceania Pty Limited. He has over twenty years experience in domestic and international trade. He was instrumental in the formation of Advanced Technologies Laboratories Pty Ltd. (now Philips Medical Systems) and Insight Oceania Pty Ltd. He was instrumental in the formation of Advanced Technologies Laboratories Pty Ltd (now Philips Medical Systems) and Insight Oceania Pty Ltd. He has been an Executive Director of Quantum Energy Ltd. since November 7, 2003. He serves as a Director of Insight Oceania Pty Limited. Mr. Walstab has a background in Industrial Electronics and Instrumentation with a strong focus on international marketing, distribution and technology.

CEO Compensation
  • John's compensation has increased in line with Quantum Health Group recently becoming profitable.
  • John's remuneration is about average for companies of similar size in Germany.
Management Team

John Walstab

TITLE
MD & Executive Director
COMPENSATION
A$397K
AGE
55
TENURE
2.3 yrs

Y. Kim

TITLE
Director of Medical Imaging
COMPENSATION
A$674K
TENURE
3.9 yrs

Steve Charlton

TITLE
General Manager of Technology
COMPENSATION
A$106K
Board of Directors Tenure

Average tenure of the Quantum Health Group board of directors in years:

15.6
Average Tenure
  • The average tenure for the Quantum Health Group board of directors is over 10 years, this suggests they are a seasoned and experienced board.
Board of Directors

Drew Townsend

TITLE
Chairman
AGE
53
TENURE
15.9 yrs

John Walstab

TITLE
MD & Executive Director
COMPENSATION
A$397K
AGE
55
TENURE
15.6 yrs

Alan McCarthy

TITLE
Non-Executive Director
TENURE
1.8 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (€) Value (€)
X
Management checks
We assess Quantum Health Group's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Quantum Health Group has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

Company Info

Description

Quantum Health Group Limited distributes medical imaging and patient treatment equipment and services in Australia, Thailand, South Korea, Vietnam, New Zealand, and China. The company was formerly known as Quantum Energy Limited. Quantum Health Group Limited was founded in 1975 and is headquartered in Sydney, Australia.

Details
Name: Quantum Health Group Limited
QD4
Exchange: DB
Founded: 1975
A$16,820,819
1,098,308,291
Website: http://www.qhealthcare.com.au
Address: Quantum Health Group Limited
50-60 Bourke Road,
Sydney,
New South Wales, 2015,
Australia
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
ASX QTM Ordinary Shares Australian Securities Exchange AU AUD 02. Jan 1992
DB QD4 Ordinary Shares Deutsche Boerse AG DE EUR 02. Jan 1992
CHIA QTM Ordinary Shares Chi-X Australia AU AUD 02. Jan 1992
Number of employees
Current staff
Staff numbers
0
Quantum Health Group employees.
Industry
Health Care Distributors
Healthcare
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/06/15 20:54
End of day share price update: 2019/06/14 00:00
Last earnings filing: 2019/02/28
Last earnings reported: 2018/12/31
Last annual earnings reported: 2018/06/30


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.